Emerging in the arena of obesity treatment, retatrutide is a unique approach. Unlike many existing medications, retatrutide works as a dual agonist, at once affecting both glucagon-like peptide-1 (GLP-1) and https://pennyuphl655517.blue-blogs.com/46485969/this-novel-retatrutide-this-glp-gip-binding-site-agonist